Posts tagged: methicillin sensitive staphylococcus aureus

MRSAid™ – High Hopes For A New Era In Infection Prevention

Over the coming year, the world will learn more about our MRSAid™ photodisinfection technology and its ability to prevent surgical site infections.  The last patients in the year long quality improvement program at Vancouver General Hospital (VGH) will be treated next month, giving us a chance to look retrospectively at how surgical site infections were affected at this major hospital. This program, involving over 5,000 patients at VGH, sought to reduce infections in all patients undergoing cardio, vascular, neurological, thoracic, breast, spinal and orthopaedic surgeries.  Data from this analysis is expected in the late fall and results are expected to be announced at Infection Control Conferences in 2013.

People who carry MRSA or MSSA are at much greater risk of self infection when they are immunocompromised and weakened after surgery. Up to 30% of patients are simply unable to defend themselves from the tenacious bacteria called Staphylococcus aureus which lie dormant in the nose, waiting for opportunities to invade the body. Eliminating the bacteria carried in the nose prior to surgery has been proven to reduce the rate of surgical site infections. From a number of other studies (including Bode et al “Preventing SSIs In Nasal Carriers of Staph”), we have learned that eliminating both MRSA and MSSA from the nose prior to surgery reduces surgical site infections (SSIs) by up to 56% and total healthcare-associated infections (HAIs) by up to 79% in non-surgical admissions.

Read more »

Related Posts Plugin for WordPress, Blogger...

Staypressed theme by Themocracy